医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Theorem Clinical Research Expands Leadership and Prepares for Growth with Addition of Kathryn Bohannon and Angela Weston

2014年11月05日 PM10:00
このエントリーをはてなブックマークに追加


 

KING OF PRUSSIA, Pa.

Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, has named Kathryn Bohannon as vice president of biopharmaceutical development and Angela Weston as vice president of business development in Europe and Asia.

Bohannon increases Theorem’s scientific and medical leadership in pediatrics and rare disease with almost 20 years of diverse pharmaceutical research and development experience, including Phase I-IV clinical research, laboratory research and development as well as U.S. and global project management and direct sales and marketing. She has developed and managed projects across multiple therapeutic areas and clinical settings, including the Best Pharmaceuticals for Children Act – Data Coordinating Center within the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Weston brings more than 20 years of experience to Theorem, spanning a broad range of commercial disciplines in the pharmaceutical, biotech and medical device industries. She has worked extensively in business development, previously serving as senior vice president for business development at a global clinical contract research organization. In this role, she organized and managed the pharmaceutical, medical device and clinical resource sales teams. Additionally, Weston is a clinical nurse specialist and paramedic.

“These professionals further enhance our capabilities and client services,” said John Potthoff, Theorem president and CEO. “We have the right experts in place to provide meaningful expertise in key aspects of clinical trials.”

Learn more about Theorem, its services and therapeutic areas of expertise at www.theoremclinical.com.

About Theorem Clinical Research

Theorem Clinical Research is a global provider of comprehensive clinical services with staff throughout the Americas, Europe and Asia and a client base comprised of the world’s leading biopharmaceutical and medical device companies. With industry-leading experts, unparalleled therapeutic expertise and innovative technology, Theorem is focused on analytic-based development, combination trials and personal data applications to simplify complex trials.

CONTACT

SCORR Marketing
Lea Studer, +1-308-237-5567
lea@scorrmarketing.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高